Literature DB >> 22815349

Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration.

Yara T E Lechanteur1, Johannes P H van de Ven, Dzenita Smailhodzic, Camiel J F Boon, B Jeroen Klevering, Sascha Fauser, Joannes M M Groenewoud, Gert-Jan van der Wilt, Anneke I den Hollander, Carel B Hoyng.   

Abstract

PURPOSE: This study was conducted to investigate the correlation of genetic, sociodemographic, and behavioral risk factors with second eye progression to end-stage AMD.
METHODS: One hundred and eight patients with end-stage AMD in one or both eyes were included in a retrospective time-to-event analysis of the onset of end-stage AMD in the second eye. Multivariate Cox regression survival analysis was performed for sex, age, smoking, body mass index (BMI), education, and 16 single nucleotide polymorphisms (SNPs) associated with AMD.
RESULTS: Except for education, all sociodemographic and behavioral risk factors analyzed were significantly associated with a more rapid progression toward second eye involvement. Hazard ratios (HRs) were 2.6 (95% confidence interval [CI], 1.4-5.0) for female sex; 5.0 (95% CI, 2.0-12.5) for age >80; 2.2 (95% CI, 1.1-4.1) for BMI >30; and 4.4 (95% CI, 1.4-14.3) for >40 pack years, compared with the referent groups. Carriers of the lipoprotein lipase (LPL; rs12678919) risk alleles were at risk for more rapid progression to end-stage AMD in the second eye compared with the referent wild-type genotype (HR 2.0; 95% CI, 1.0-3.6). For complement factor I (CFI; rs10033900), homozygous carriers of the risk allele progressed faster than wild-type individuals (HR 2.2; 95% CI, 1.1-4.3).
CONCLUSIONS: Sociodemographic, behavioral, and genetic risk factors are associated with the rate of second eye progression toward end-stage AMD. The findings of this study underline the importance of lifestyle factors and the complement pathway in AMD progression and suggest a role of the high-density-lipoprotein metabolism in second eye progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815349     DOI: 10.1167/iovs.11-7731

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Jeong Won Pak; Ronald P Danis; Peter W Hunt
Journal:  Am J Ophthalmol       Date:  2017-05-10       Impact factor: 5.258

2.  Retinoid analogs and polyphenols as potential therapeutics for age-related macular degeneration.

Authors:  Tanu Parmar; Joseph T Ortega; Beata Jastrzebska
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

3.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

4.  Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.

Authors:  Maureen G Maguire; Ebenezer Daniel; Ankoor R Shah; Juan E Grunwald; Stephanie A Hagstrom; Robert L Avery; Jiayan Huang; Revell W Martin; Daniel B Roth; Alessandro A Castellarin; Sophie J Bakri; Stuart L Fine; Daniel F Martin
Journal:  Ophthalmology       Date:  2013-05-22       Impact factor: 12.079

5.  Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes.

Authors:  Alvaro Velazquez-Villoria; Sergio Recalde; Jaouad Anter; Jaione Bezunartea; Maria Hernandez-Sanchez; Laura García-García; Elena Alonso; Jose María Ruiz-Moreno; Javier Araiz-Iribarren; Patricia Fernandez-Robredo; Alfredo García-Layana
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

Review 6.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22

7.  Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Jeong Won Pak; Ronald P Danis; Peter W Hunt
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

Review 8.  Risk factors for progression of age-related macular degeneration.

Authors:  Thomas J Heesterbeek; Laura Lorés-Motta; Carel B Hoyng; Yara T E Lechanteur; Anneke I den Hollander
Journal:  Ophthalmic Physiol Opt       Date:  2020-02-25       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.